HomeOpen Access NewsInfectious Diseases

Infectious Diseases

University of Oxford launches first human aerosol TB vaccine trial

The University of Oxford has commenced a new clinical trial called TB-45, which will test the safety of a new tuberculosis (TB) vaccine.

Double vaccination reduces risk of Long COVID by 49%

Double vaccinated adults are 49% less likely to have Long COVID if they were to contract COVID-19, according to a new study.

Five new research projects will examine COVID-19 vaccine responses

Five new COVID-19 research projects will study the durability of vaccine responses, low responses linked with health conditions and the effect of booster shots.

Clinical trial to test third COVID-19 vaccine for people with weakened immune systems

A new clinical trial will investigate whether a third COVID-19 vaccine dose gives a stronger immune response for people with weakened immune systems.

The risks of using alcohol-based hand sanitiser

Dr Deborah Lee from Dr Fox Online Pharmacy, reveals the risks of using alcohol-based hand sanitiser.

Campaigners call for approval of life saving COVID-19 antibody treatments

A group of patient bodies, charities and senior clinicians have urged the Government to approve the use of life-saving COVID-19 antibody treatments.

COVID-19 reveals the underappreciated burden of smell disorders

Chrissi Kelly, Founder of the charity AbScent, explains that COVID-19 reveals the underappreciated burden of smell disorders.

Self-isolation rules removed for fully vaccinated close contacts

Fully vaccinated individuals will no longer be legally required to self-isolate if they come into contact with a positive COVID-19 case.

COVID-19 booster jab will offer better protection against variants

COVID-19 booster jab will protect people from existing, and potentially future, variants, according to scientists at the University of Nottingham.

COVID-19 infection linked to preterm births

Pregnant individuals who contract COVID-19 face a higher risk of having a preterm birth, according to researchers at The University of California, San Francisco (UCSF).

Rare case of brain inflammation after mild COVID-19 infection

Physicians at University of California San Diego School of Medicine describe the first known case of a young, healthy adult who suffered brain inflammation after mild COVID-19 infection.

Fenofibrate could reduce COVID-19 infection by 70%

According to a new study, fenofibrate, a drug used to treat abnormal levels of fatty substances in the blood, could reduce COVID-19 infection by up to 70%.

Pfizer-BioNTech vaccine to be offered to 16-17-year-olds

The Joint Committee on Vaccination and Immunisation (JCVI) has recommended that all 16 and 17-year-olds should receive their first dose of the Pfizer-BioNTech vaccine.

European commission approves contract for Novavax vaccine

The European Commission has approved a new contract that will allow Member States to purchase up to 100 million doses of the Novavax vaccine.

NHS Track and Trace app will ‘ping’ fewer contacts to isolate

Fewer contacts will be notified to self-isolate following updates to the NHS COVID-19 Track and Trace app.

Clinical trial to investigate vaccine dose interval for pregnant women

A new clinical trial, funded by the UK government, will investigate the best gap between the first and second COVID-19 vaccine dose for pregnant women.

£1.1 million given for Long Covid research

A new research project, known as LISTEN, has been awarded £1.1 million of UK government funding to support people with Long Covid.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders